Aeromonas characteristics in Iran, Southwest Asia; a systematic review and meta-analysis on epidemiology, reservoirs and antibiotic resistance profile from aquatic environments to human society during 2000-2023
Systematic review and meta-analysis published in BMC veterinary research (2025)
Resumen
BACKGROUND: As recent evidence shows the prevalence and transmission of Aeromonas species in Southwest Asia, and there is no updated information on the characteristics of Aeromonas in Iran, we conducted this review. We systematically searched biomedical databases (PubMed, Web of Sciences, Scopus, SID, ISC, and Google Scholar) to identify relevant studies investigating the prevalence, antibiotic resistance, and main reservoirs of Aeromonas in aquatic animals and human clinical specimens during 2000-2023 in Iran. Cochrane's Q test and I^2 statistical test was used to assess heterogeneity, and publication bias was assessed using funnel plots and random effects tests. RESULTS: In Iran, among 8347 human clinical samples and 1802 animal and food samples, only 87 (1.04%) and 388 (21.53%) samples were positive for Aeromonas spp. respectively, and the most isolated species was A. hydrophila. The main reservoir for Aeromonas spp. were twenty-four genera of aquatic animals besides minced meat, pigeon stool and chicken meat. In Iran, Aeromonas spp. isolates showed maximum resistance to ampicillin, tetracycline, nalidixic acid and vancomycin. The heterogeneity test for prevalence of Aeromonas species on human samples and animals or food products was significant (88.1256, (5), P-value < 0.0001) and the heterogeneity rate was 97.34% with a confidence interval of 0.2-4.3 and (194.02, (10), P-value < 0.0001) and the heterogeneity rate was 94.85% with a confidence interval of 15,124 - 33,335 respectively. CONCLUSIONS: According to these results, it is essential for exclusive attention to the prevalence and antibiotic resistance of Aeromonas in different provinces of Iran. Furthermore, special planning should be done for prevention, outbreak control and proper treatment of infections in the aquaculture industry and human societies.
Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.
El resumen se deja sin traducir para conservar la redacción original de los autores.
Síntesis
A systematic review of Iranian studies (2000-2023) found Aeromonas in 1.04% of human clinical samples and 21.53% of animal/food samples, dominated by A. hydrophila, with high resistance to ampicillin, tetracycline, nalidixic acid, and vancomycin.
Por qué esto importa para la hirudoterapia
Esta revisión sistemática y metaanálisis de datos iraníes (2000-2023) agrupó 8,347 muestras clínicas humanas y 1,802 muestras de animales/alimentos, hallando una positividad para Aeromonas del 1.04% en muestras humanas y del 21.53% en muestras de animales/alimentos (más comúnmente A. hydrophila), con una resistencia máxima a ampicilina, tetraciclina, ácido nalidíxico y vancomicina. La conexión con la hirudoterapia es relevante porque Aeromonas (destacando A. hydrophila) es el simbionte intestinal implicado en las infecciones de heridas posteriores a la terapia con sanguijuelas, por lo que los patrones regionales de resistencia a los antibióticos orientan las decisiones de profilaxis y la advertencia de larga data de que la cobertura con la clase de fluoroquinolonas es típica. Advertencias: este metaanálisis se centra en la epidemiología de Aeromonas del entorno acuático y clínico general en un solo país, no en las infecciones por terapia con sanguijuelas específicamente; los autores reportan una alta heterogeneidad estadística (I^2 ~95-97%); y los perfiles de resistencia son específicos geográfica y temporalmente, por lo que no pueden generalizarse a la profilaxis para la terapia con sanguijuelas en otros lugares sin datos locales.
Citación
Aeromonas characteristics in Iran, Southwest Asia; a systematic review and meta-analysis on epidemiology, reservoirs and antibiotic resistance profile from aquatic environments to human society during 2000-2023.
Moradi et al. · BMC veterinary research, 2025
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Investigación relacionada
Más estudios revisados por pares en la categoría «Resistencia antimicrobiana».
- Novel Leech Antimicrobial Peptides — Hirunipins — Kumar et al. (2025)
- Leech therapy (Hirudo medicinalis) attenuates testicular damages induced by testicular ischemia/reperfusion in an animal model — Davoodi F et al. (2021)
- AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech — Baranzini N et al. (2019)
- Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens — Grafskaia E et al. (2019)
- Antimicrobial Role of RNASET2 Protein During Innate Immune Response in the Medicinal Leech Hirudo verbana — Baranzini N et al. (2020)
- Morganella Morganii Infection in Hirudo Medicinalis (Iran): A Case Report — Rahmati Holasoo H et al. (2022)
- Clinical efficacy of Jalaukawacharana (leech application) in Thrombosed piles — Bhagat P, Raut S, Lakhapati A (2012)
- Determination of disulfide linkages in antimicrobial peptides of the macin family by combination of top-down and bottom-up proteomics — Hung CW, Jung S, Grötzinger J, Gelhaus C, Leippe M, Tholey A (2014)
- Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum — Tasiemski A, Vandenbulcke F, Mitta G, Lemoine J, Lefebvre C, Sautière PE, Salzet M (2004)
- Macin family of antimicrobial proteins combines antimicrobial and nerve repair activities — Jung S, Sönnichsen FD, Hung CW et al. (2012)
Añadido a la biblioteca ASH: 28 de mayo de 2026 · Última actualización del sitio: 18 de junio de 2026